Glucotrack, Inc.

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GCTKNasdaqHealthcareMedical Instruments & Supplies
$0.61 -0.06 (-8.87%)

Company Overview

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Price Chart

Historical Trend (Absolute Values)
GCTK Price
05/2005/2906/05

Financial Metrics

Market Capitalization$3.79M
P/E Ratio0.0967
Earnings Per Share (EPS)$6
Dividend Yield
Beta (Volatility)
Price to Book (P/B)-1.7982
52-Week Range$0.43 - $15.90

LAST SCRARED: June 6, 2026

Compare GCTK

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.